Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Retained Earnings (2023 - 2026)

Camp4 Therapeutics' Retained Earnings history spans 3 years, with the latest figure at -$292.2 million for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 37.99% to -$292.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$292.2 million, a 37.99% decrease, with the full-year FY2025 number at -$292.2 million, down 37.99% from a year prior.
  • Retained Earnings hit -$292.2 million in Q4 2025 for Camp4 Therapeutics, down from -$251.9 million in the prior quarter.
  • Over the last five years, Retained Earnings for CAMP hit a ceiling of -$160.0 million in Q4 2023 and a floor of -$292.2 million in Q4 2025.
  • Historically, Retained Earnings has averaged -$225.0 million across 3 years, with a median of -$224.2 million in 2025.
  • The widest YoY moves for Retained Earnings: up 26.9% in 2025, down 37.99% in 2025.
  • Tracing CAMP's Retained Earnings over 3 years: stood at -$160.0 million in 2023, then tumbled by 32.38% to -$211.8 million in 2024, then tumbled by 37.99% to -$292.2 million in 2025.
  • Business Quant data shows Retained Earnings for CAMP at -$292.2 million in Q4 2025, -$251.9 million in Q3 2025, and -$236.8 million in Q2 2025.